| References |
|
|
Alvarez-Fernandez M,
Barrett AJ,
Gerhartz B, et al.
(1999)
Inhibition of mammalian legumain by some cystatins is due to a novel second reactive site.
Journal of Biological Chemistry
274: 1919619200.
|
|
|
Auerswald EA,
Nagler DK,
Gross S, et al.
(1996)
Hybrids of chicken cystatin with human kininogen domain 2 sequences exhibit novel inhibition of calpain, improved inhibition of acticidin and impaired inhibition of papain, cathepsin L and cathepsin B.
European Journal of Biochemistry
235: 534542.
|
|
|
Auerswald EA,
Rossler D,
Mentele R and
Assfalg-Machleidt I
(1993)
Cloning, expression and characterization of human kininogen domain 3.
Federation of European Biochemical Society
321: 9397.
|
|
|
Baron AC,
DeCarlo AA and
Featherstone JDB
(1999)
Functional aspects of the human salivary cystatins in the oral environment.
Oral Disease
5: 234240.
|
|
|
Foghsgaard L,
Wissing D,
Mauch D, et al.
(2001)
Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor.
Journal of Cell Biology
153: 9991009.
|
|
|
Henskens YMC,
Veerman ECI and
Amerongen AVN
(1996)
Cystatins in health and disease.
Biological Chemistry Hoppe-Seyler
377: 7186.
|
|
|
Hiltke TR,
Lee TC and
Bobek LA
(1999)
Structure/function analysis of human cystatin SN and comparison of the cysteine proteinase inhibitory profiles of human cystatins C and SN.
Journal of Dental Research
78: 14011409.
|
|
|
Morita M,
Hara Y,
Tamai Y,
Arakawa H and
Nishimura S
(2000)
Genomic construct and mapping of the gene for CMAP (leukocystatin/cystatin F, CST-7) and identification of a proximal novel gene, BSCv (C20orf3).
Genomics
67: 8791.
|
|
|
Pennacchio LA,
Bouley DM,
Higgins KM, et al.
(1998)
Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice.
Nature Genetics
20: 251258.
|
|
|
book
Shridhar R,
Sloane BF and
Keppler D
(2000)
"Inhibitors of papain-like cysteine peptidases in cancer".
In: Von der Helm K,
Korant BD and
Cheronis JC (eds.)
Handbook of Experimental Pharmacology
140: 301328.
|
|
|
Taupin P,
Ray J,
Fischer WH, et al.
(2000)
FGF-2 responsive neural stem cell proliferation requires CCg, a novel autocrine/paracrine cofactor.
Neuron
28: 385397.
|
| Further Reading |
|
|
Abrahamson M
(1994)
Cystatins.
Methods in Enzymology
244: 685700.
|
|
|
Abrahamson M,
Barrett AJ,
Salvesen G and
Grubb A
(1986)
Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids.
Journal of Biological Chemistry
261: 1128211289.
|
|
|
Abrahamson M,
Jonsdottir S,
Olafsson I,
Jensson O and
Grubb A
(1992)
Hereditary cystatin C amyloid angiopathy: identification of the disease-causing mutation and specific diagnosis by polymerase chain reaction based analysis.
Human Genetics
89: 377380.
|
|
|
Barrett AJ,
Kembhavi AA,
Brown MA, et al.
(1982)
L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L.
Biochemical Journal
201: 189198.
|
|
|
Bode W,
Engh R,
Musil D, et al.
(1988)
The 2.0 Å X-ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases.
European Molecular Biology Organization Journal
7: 25932599.
|
|
|
Colman RW
(1996)
Inhibitory and antiadhesive properties of human kininogens.
Immunopharmacology
32: 918.
|
|
|
Kirschke H,
Barrett AJ and
Rawlings ND
(1995)
Lysosomal cysteine proteinases.
Protein Profile
2: 16131619.
|
|
|
Lah TT and
Kos J
(1998)
Cysteine proteinases in cancer progression and their clinical relevance for prognosis.
Biological Chemistry
379: 125130.
|
|
|
Sloane BF,
Rozhin J,
Robinson D and
Honn KV
(1990)
Role for cathepsin B and cystatins in tumor growth and progression.
Biological Chemistry Hoppe-Seyler
371(supplement): 193198.
|
|
|
Turk V and
Bode W
(1991)
The cystatins: protein inhibitors of cysteine proteinases.
Federation of European Biochemical Society Letters
285: 213219.
|